YVONNE PIERCE: Open Payments
NPI 1952773715 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 12 payments from 8 companies in 2025. Trend: 2023 $438 · 2024 $603 · 2025 $340
Food & beverage: $240Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $145 |
| Novo Nordisk Inc | 2 | $43 |
| Exeltis, USA Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| Organon LLC | 1 | $22 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $20 |
| MILLICENT US INC | 1 | $19 |
Products named: Veozah, SLYND, Kyleena, ZEPBOUND, Rybelsus, NEXPLANON, Wegovy, FEMLYV.
Industry payments across VA — which companies pay providers there.
